Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Holmes

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
JMIR Research Protocols|February 15, 2019
Determining Best Practices for Management of Bacteriuria in Spinal Cord Injury: Protocol for a Mixed-Methods StudyFelicia Skelton, Lindsey Ann Martin, Charlesnika T Evans, et al.
American Journal of Physical Medicine & Rehabilitation|September 10, 2003
Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injuryFaye Y Chiou-Tan, Hector Garza, Kwai-Tung Chan, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
Phase II trial of 10-EDAM in the treatment of metastatic breast cancerGarth A Beinart, Ana M Gonzalez-Angulo, Kristine Broglio, et al.
Clinical Breast Cancer|March 7, 2020
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast CancerReshma Mahtani, Frankie-Ann Holmes, Sunil Badve, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 2012
Effectiveness of supported employment for veterans with spinal cord injuries: results from a randomized multisite studyLisa Ottomanelli, Lance L Goetz, Alina Suris, et al.
BMC Research Notes|December 6, 2013
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signalingFrankie Ann Holmes, Virginia Espina, Lance A Liotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With LetrozoleLea K Krekow, Beth A Hellerstedt, Rufus P Collea, et al.
Ear and Hearing|May 5, 2023
Neural Correlates of Individual Differences in Speech-in-Noise Performance in a Large Cohort of Cochlear Implant UsersJoel I Berger, Phillip E Gander, Subong Kim, et al.
Cancer Medicine|March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancerFrankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
JMIR Research Protocols|February 15, 2019
Determining Best Practices for Management of Bacteriuria in Spinal Cord Injury: Protocol for a Mixed-Methods StudyFelicia Skelton, Lindsey Ann Martin, Charlesnika T Evans, et al.
American Journal of Physical Medicine & Rehabilitation|September 10, 2003
Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injuryFaye Y Chiou-Tan, Hector Garza, Kwai-Tung Chan, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
Phase II trial of 10-EDAM in the treatment of metastatic breast cancerGarth A Beinart, Ana M Gonzalez-Angulo, Kristine Broglio, et al.
Clinical Breast Cancer|March 7, 2020
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast CancerReshma Mahtani, Frankie-Ann Holmes, Sunil Badve, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 2012
Effectiveness of supported employment for veterans with spinal cord injuries: results from a randomized multisite studyLisa Ottomanelli, Lance L Goetz, Alina Suris, et al.
BMC Research Notes|December 6, 2013
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signalingFrankie Ann Holmes, Virginia Espina, Lance A Liotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With LetrozoleLea K Krekow, Beth A Hellerstedt, Rufus P Collea, et al.
Ear and Hearing|May 5, 2023
Neural Correlates of Individual Differences in Speech-in-Noise Performance in a Large Cohort of Cochlear Implant UsersJoel I Berger, Phillip E Gander, Subong Kim, et al.
Cancer Medicine|March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancerFrankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
Pageof 5